Cargando…

The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state

BACKGROUND: The impact of public health policies during the COVID-19 pandemic on people who inject drugs (PWID) has varied across regions. In other countries, recent research has shown that PWID access to harm reduction services, despite rapid adaptations, has been negatively impacted. Our study des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thakarar, Kinna, Kohut, Michael, Hutchinson, Rebecca, Bell, Rebecca, Loeb, Hannah E., Burris, Debra, Fairfield, Kathleen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305035/ https://www.ncbi.nlm.nih.gov/pubmed/35869523 http://dx.doi.org/10.1186/s12954-022-00660-2

Ejemplares similares

1418. Injections and Infections: Understanding Harm Reduction Utilization in a Rural State
por: Thakarar, Kinna, et al.
Publicado: (2020)

1050. Hepatitis C Infection amongst People who Inject Drugs (PWID): Injection Practices and Risk Factors
por: Sankar, Nityasri, et al.
Publicado: (2020)

Health care professional perspectives on discharging hospitalized patients with injection drug use-associated infections
por: Moore, Nichole, et al.
Publicado: (2022)

Injections and infections: understanding syringe service program utilization in a rural state
por: Thakarar, Kinna, et al.
Publicado: (2021)

‘I feel like they’re actually listening to me’: a pilot study of a hospital discharge decision-making conversation guide for patients with injection drug use–associated infections
por: Thakarar, Kinna, et al.
Publicado: (2023)

“I know my body better than anyone else”: a qualitative study of perspectives of people with lived experience on antimicrobial treatment decisions for injection drug use-associated infections
por: Eckland, Amy, et al.
Publicado: (2023)

Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services
por: Thakarar, Kinna, et al.
Publicado: (2019)

Rural–Urban Differences in Hospitalizations for Opioid Use–Associated Infective Endocarditis in the United States, 2003–2016
por: Nenninger, E Katherine, et al.
Publicado: (2020)

1319. Examining PrEP Knowledge and Prescribing Likelihood Among Medical Residents Before and After PrEP Education
por: Christian, Elizabeth, et al.
Publicado: (2018)

Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass Resistance
por: Nagami, Ellen H, et al.
Publicado: (2021)

Decisions about adopting novel COVID‐19 vaccines among White adults in a rural state, USA: A qualitative study
por: Kohut, Mike, et al.
Publicado: (2023)

Measures of harm reduction service provision for people who inject drugs
por: O’Keefe, Daniel, et al.
Publicado: (2019)

1793. Pipes as a Harm Reduction Tool: Insights from People Who Use Methamphetamine in Rural Illinois
por: Rains, Alex, et al.
Publicado: (2023)

Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth
por: Stone, Katie Alexandra
Publicado: (2015)

Migration to the US among rural Puerto Ricans who inject drugs: influential factors, sources of support, and challenges for harm reduction interventions
por: Abadie, R., et al.
Publicado: (2019)

Gender-based vulnerability in women who inject drugs in a harm reduction setting
por: Valencia, Jorge, et al.
Publicado: (2020)

Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care
por: Chatterjee, Avik, et al.
Publicado: (2023)

Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs
por: Nolan, Nathanial S, et al.
Publicado: (2023)

“We don't need services. We have no problems”: exploring the experiences of young people who inject drugs in accessing harm reduction services
por: Krug, Anita, et al.
Publicado: (2015)

Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response
por: Wilkinson, Rebecca, et al.
Publicado: (2020)

Predictors of Frequent Emergency Room Visits among a Homeless Population
por: Thakarar, Kinna, et al.
Publicado: (2015)

Co-design of harm reduction materials for people who inject drugs to implement research findings
por: Hussey, Deborah, et al.
Publicado: (2019)

Population estimation and harm reduction among people who inject drugs in Addis Ababa, Ethiopia
por: Deyessa, Negussie, et al.
Publicado: (2020)

Guideline development in harm reduction: Considerations around the meaningful involvement of people who access services
por: Adams, Alison, et al.
Publicado: (2022)

Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services
por: Croxford, S., et al.
Publicado: (2021)

Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions
por: Palmateer, Norah E., et al.
Publicado: (2014)

Food access among people who inject drugs in West Virginia
por: Rouhani, Saba, et al.
Publicado: (2021)

A preliminary needs assessment of American Indians who inject drugs in northeastern Montana
por: Anastario, Mike, et al.
Publicado: (2017)

Assessing seasonality of travel distance to harm reduction service providers among persons who inject drugs
por: Allen, Sean T., et al.
Publicado: (2015)

1535. Harm Reduction: A Missing Piece in Holistic ID Care for Patients Who Inject Drugs
por: Fracasso Francis, Sarah M, et al.
Publicado: (2022)

Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois
por: Rains, Alex, et al.
Publicado: (2022)

SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya
por: Doshi, Shradha, et al.
Publicado: (2023)

Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs
por: Trayner, Kirsten M.A., et al.
Publicado: (2020)

Opportunities to Offer Harm Reduction to People who Inject Drugs During Infectious Disease Encounters: Narrative Review
por: Peckham, Alyssa M, et al.
Publicado: (2020)

Young people who inject drugs in Mozambique: should we emphasize them in the National Harm Reduction Plan?
por: Semá Baltazar, Cynthia, et al.
Publicado: (2020)

Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: findings from the 2019 Harm Reduction Client Survey
por: Steinberg, Abigail, et al.
Publicado: (2022)

Who Pays for Open Access?
por: Doyle, Helen, et al.
Publicado: (2004)

The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings
por: Bolinski, Rebecca S., et al.
Publicado: (2022)

Effectiveness of the behavior change intervention to improve harm reduction self-efficacy among people who inject drugs in Thailand
por: Pawa, Duangta, et al.
Publicado: (2016)

Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study
por: Uusküla, Anneli, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j7s3gc3cu6tjc9nci9pl9k4uvc